2014
DOI: 10.3109/09273948.2014.894766
|View full text |Cite
|
Sign up to set email alerts
|

The Promise and Limitations of TNF-α Inhibition for Uveitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…Others [18][19][20] have reported the use of anti-TNF-a agents, including adalimumab, 15 to treat SC, supporting the broad utility of TNF-a inhibitors in patients with noninfectious uveitis. 21,22 Together, these four studies highlight important features of SC and MSC, including the utility of both multimodal imaging and ancillary testing; the frequent need for non-corticosteroid immunosuppressive therapy; 23 and the importance of excluding systemic infection in patients with placoid lesions involving the outer retina and inner choroid -most notably infection by M. tuberculosis.…”
mentioning
confidence: 99%
“…Others [18][19][20] have reported the use of anti-TNF-a agents, including adalimumab, 15 to treat SC, supporting the broad utility of TNF-a inhibitors in patients with noninfectious uveitis. 21,22 Together, these four studies highlight important features of SC and MSC, including the utility of both multimodal imaging and ancillary testing; the frequent need for non-corticosteroid immunosuppressive therapy; 23 and the importance of excluding systemic infection in patients with placoid lesions involving the outer retina and inner choroid -most notably infection by M. tuberculosis.…”
mentioning
confidence: 99%